McCormick, P A <br/><br/>
A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Apr 1997 
 - 833-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1002/hep.510250408  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Ceftazidime--therapeutic use<br/>Cephalosporins--therapeutic use<br/>Drug Therapy, Combination--administration & dosage<br/>Female<br/>Gentamicins--administration & dosage<br/>Humans<br/>Kidney--drug effects<br/>Liver Cirrhosis--complications<br/>Male<br/>Mezlocillin--administration & dosage<br/>Middle Aged<br/>Netilmicin--administration & dosage<br/>Penicillins--administration & dosage<br/>Prospective Studies<br/>Sepsis--complications